The Use of Hip Protectors in Long-Term Care Facilities: A Survey of Nursing Home Staff
Objectives
To determine the level of exposure to hip protectors and barriers to their use in nursing homes.
Design, Setting, and Participants
We conducted a written survey of 160 staff (including administrators) in 5 nursing homes in the Hamilton-Wentworth region, Ontario, Canada.
Measurements
The results of primary analyses were expressed as percentage of respondents.
Results
Among respondents of respective institutions, the rate of prior exposure to hip protectors varied from 40.9% to 100.0% and the rate of prior experience applying these devices varied from 14.3% to 80.0%. The most frequently cited main barriers to the use of hip protectors in long-term care facilities included physicians not thinking to prescribe them, expense, lack of evidence of benefit in this population, wearer discomfort, and wearer removal. A lack of staff time to apply these devices was rarely cited. The majority of staff believed that nursing home residents with a prior history of fracture, those who fall frequently, or those who are unsteady on their feet should wear hip protectors.
Conclusions
The exposure of surveyed nursing home staff to hip protectors was variable but most agreed that residents who are at increased risk of hip fracture should wear them. Some identified barriers to the use of hip protectors in long-term care facilities were physicians not thinking to prescribe them, expense, lack of evidence of benefit in this population, wearer discomfort, and wearer removal. Such barriers need to be addressed for hip protector implementation strategies to be successful in nursing homes.
Keywords: Hip protectors, hip fracture, nursing home
To access this article, please choose from the options below
This study was funded by an Interdisciplinary Capacity Enhancement (ICE) Team Grant focused on Reducing the Burden of Injury in Canada from The Canadian Institutes of Health Research (CIHR). Co-investigators on the ICE project are P. Raina, C. Macarthur, P. Holowaty, A. Howard, B. Morrongiello, and H. Shannon. Reviewers from the sponsoring agency provided a critique of the study design and methods at the grant application stage but the sponsoring agency had no further direct role in the study. Anna Sawka is a Canadian Institutes of Health Research New Investigator.
The authors have no conflicts of interest to declare related to the subject of this manuscript.
PII: S1525-8610(06)00625-6
doi:10.1016/j.jamda.2006.12.023
© 2007 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.
